Why work with Nucleus Network?

Nucleus Network has not-for-profit status. The organisation is a wholly owned subsidiary of BakerIDI Heart and Diabetes Institute with and independent Board headquartered in Melbourne, Australia. The not-for-profit status of Nucleus Network provides unique collaborations with hospital based principal investigators, individual researchers, medical schools and access to dedicated research precinct facilities and capabilities. This status also allows for re-investment in the business to assure highest standards of training, facilities and equipment.

**Features and Benefits of working with Nucleus Network**
Feature	Benefit
No central regulatory approval needed before trial commencement (CTN process).	Fast start - favourable regulatory environment.
Developed country. Hight quality, ICH- GCP studies.	Nucleus Network is recognised for the quality of its clinical research which is conducted in a recognised and robust ethical, legal and regulatory first world environment with all clinical data generated acceptable to the US FDA and European EMEA standards.
Cost-effective.	Exchange rate advantages.
Multicultural population of 21million people.	Caucasian, Japanese and Chinese healthy and patient cohorts for ethnopharmacological studies.
Qualified and accredited clinical researchers.	Staff have a depth of experience, extensive training and GCP certification.
Dedicated trial facilities. Easy access to high tech infrastructure eg PET/ MRI, specialist groups and clinical trial manufacturing, packaging and logistical services.	Excellent network of early phase clinical trials service providers that can be managed directly by Nucleus Network.
Teaching hospital, research institute, Nucleus Network location.	Ability to create customised biomarker assays and work with principal investigators who are experienced in clincial trials.
Ability to utilse clinical trial manufacturing, packaging and logistical services and small scale secondary packaging services.	"Just-in-time" services accessible from Nucleus Network. - logistical services including quarantined storage of Clinical Trial Supplies prior to local ethics approvals to enable faster trial start up.